Shanghai Titan Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Shanghai Titan Scientific has a total shareholder equity of CN¥2.9B and total debt of CN¥1.5B, which brings its debt-to-equity ratio to 51.6%. Its total assets and total liabilities are CN¥4.8B and CN¥2.0B respectively. Shanghai Titan Scientific's EBIT is CN¥19.5M making its interest coverage ratio 0.7. It has cash and short-term investments of CN¥978.4M.
Key information
51.6%
Debt to equity ratio
CN¥1.47b
Debt
| Interest coverage ratio | 0.7x |
| Cash | CN¥978.44m |
| Equity | CN¥2.86b |
| Total liabilities | CN¥1.98b |
| Total assets | CN¥4.85b |
Recent financial health updates
No updates
Recent updates
Shanghai Titan Scientific Co., Ltd.'s (SHSE:688133) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Oct 01
Shanghai Titan Scientific's (SHSE:688133) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Sep 05Returns On Capital Signal Tricky Times Ahead For Shanghai Titan Scientific (SHSE:688133)
Aug 30Shanghai Titan Scientific Co., Ltd. (SHSE:688133) Not Flying Under The Radar
Aug 07At CN¥16.04, Is Shanghai Titan Scientific Co., Ltd. (SHSE:688133) Worth Looking At Closely?
Jun 28Shanghai Titan Scientific Co., Ltd.'s (SHSE:688133) Stock Retreats 27% But Earnings Haven't Escaped The Attention Of Investors
Apr 16Should You Think About Buying Shanghai Titan Scientific Co., Ltd. (SHSE:688133) Now?
Mar 26Financial Position Analysis
Short Term Liabilities: 688133's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 688133's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥460.4M).
Debt to Equity History and Analysis
Debt Level: 688133's net debt to equity ratio (17.4%) is considered satisfactory.
Reducing Debt: 688133's debt to equity ratio has increased from 30.9% to 51.6% over the past 5 years.
Debt Coverage: 688133's debt is not well covered by operating cash flow (6.3%).
Interest Coverage: 688133's interest payments on its debt are not well covered by EBIT (0.7x coverage).